Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

OLYMPUS INORGANIC PHOSPHORUS (2-REAGENT MODIFICA.)

K-Number: K901807 · 1990-05-02

ApplicantEm Diagnostic Systems, Inc.
Decision Date1990-05-02
Product CodeCEO
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

OLYMPUS INORGANIC PHOSPHORUS (2-REAGENT MODIFICA.) is the device name listed in this FDA 510(k) record. The listed applicant is Em Diagnostic Systems, Inc.. It received FDA 510(k) clearance on 1990-05-02 under 510(k) number K901807. The device is classified under product code CEO. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OLYMPUS INORGANIC PHOSPHORUS (2-REAGENT MODIFICA.)?

OLYMPUS INORGANIC PHOSPHORUS (2-REAGENT MODIFICA.) is a medical device that received FDA 510(k) clearance on 1990-05-02. The listed applicant is Em Diagnostic Systems, Inc.. The 510(k) number is K901807.

When did OLYMPUS INORGANIC PHOSPHORUS (2-REAGENT MODIFICA.) receive FDA 510(k) clearance?

OLYMPUS INORGANIC PHOSPHORUS (2-REAGENT MODIFICA.) received FDA 510(k) clearance on 1990-05-02, under 510(k) number K901807.

Who is the listed applicant for OLYMPUS INORGANIC PHOSPHORUS (2-REAGENT MODIFICA.)?

The FDA 510(k) record lists Em Diagnostic Systems, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for OLYMPUS INORGANIC PHOSPHORUS (2-REAGENT MODIFICA.)?

The FDA product code for OLYMPUS INORGANIC PHOSPHORUS (2-REAGENT MODIFICA.) is CEO.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Em Diagnostic Systems, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K935181ASPARTATE AMINOTRANSFERASE (AST) TESTK935180ALANINE AMINOTRANSFERASE (ALT) TESTK935178EMDS PHOSPHOROUS (PHOS) TESTK935179EMDS ALBUMIN (ALB) TESTK935175LACTATE DEHYDROGENASE (LD)K935174TOTAL PROTEIN TEST (TPRO)

View all 288 devices →

Related Devices (Code: CEO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K100263ELITECH CLINICAL SYSTEMS PHOSPHORUS, URIC ACID MONO SL AND UREA UV SL REAGENTSSeppim S.A.S.K072141S40 CLINICAL ANALYZER, S TEST IP, S TEST UAAlfa Wassermann Diagnostic Technologies, Inc.K041643SYNCHRON SYSTEMS PHOSPHORUS (PHS) REAGENTBeckman Coulter, Inc.K030015ATAC PAK PHOSPHORUS REAGENTElan DiagnosticsK022312PICCOLO PHOSPHORUS TEST SYSTEMAbaxis, Inc.K013095WIENER LAB.FOSFATEMIA UV, MODELS 1X100 ML CAT.N 1382321, 4X20 ML CAT.N 1009311Wiener Laboratories Saic

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑